233 related articles for article (PubMed ID: 12639928)
21. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
22. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
Widmann C; Bürki E; Dolci W; Thorens B
Mol Pharmacol; 1994 May; 45(5):1029-35. PubMed ID: 8190093
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ
Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
[TBL] [Abstract][Full Text] [Related]
24. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.
Lee JW; Swick AG; Romsos DR
Exp Biol Med (Maywood); 2003 Feb; 228(2):175-82. PubMed ID: 12563024
[TBL] [Abstract][Full Text] [Related]
25. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.
Salehi A; Ekelund M; Lundquist I
Horm Metab Res; 2003 Jan; 35(1):48-54. PubMed ID: 12669271
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
Wang X; Zhou J; Doyle ME; Egan JM
Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
[TBL] [Abstract][Full Text] [Related]
27. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor.
Buteau J; Foisy S; Joly E; Prentki M
Diabetes; 2003 Jan; 52(1):124-32. PubMed ID: 12502502
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
[TBL] [Abstract][Full Text] [Related]
30. Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1.
Holz GG; Leech CA; Habener JF
J Biol Chem; 1995 Jul; 270(30):17749-57. PubMed ID: 7543091
[TBL] [Abstract][Full Text] [Related]
31. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Lawrence MC; Bhatt HS; Easom RA
Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
[TBL] [Abstract][Full Text] [Related]
32. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids.
Abrahamsen N; Nishimura E
Endocrinology; 1995 Apr; 136(4):1572-8. PubMed ID: 7534705
[TBL] [Abstract][Full Text] [Related]
33. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
34. Regulation of glucagon-like peptide-1 receptor and calcium-sensing receptor signaling by L-histidine.
Leech CA; Habener JF
Endocrinology; 2003 Nov; 144(11):4851-8. PubMed ID: 12959987
[TBL] [Abstract][Full Text] [Related]
35. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
Dillon JS; Lu M; Bowen S; Homan LL
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
[TBL] [Abstract][Full Text] [Related]
36. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway.
Liu FQ; Zhang XL; Gong L; Wang XP; Wang J; Hou XG; Sun Y; Qin WD; Wei SJ; Zhang Y; Chen L; Zhang MX
Mol Cell Endocrinol; 2011 Jun; 339(1-2):25-33. PubMed ID: 21458523
[TBL] [Abstract][Full Text] [Related]
38. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
Abraham EJ; Leech CA; Lin JC; Zulewski H; Habener JF
Endocrinology; 2002 Aug; 143(8):3152-61. PubMed ID: 12130581
[TBL] [Abstract][Full Text] [Related]
39. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.
Zhou J; Montrose-Rafizadeh C; Janczewski AM; Pineyro MA; Sollott SJ; Wang Y; Egan JM
J Cell Physiol; 1999 Dec; 181(3):470-8. PubMed ID: 10528233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
